Takeda Pharmaceutical Co., Ltd. (TAK)
18.30
+0.06
(+0.30%)
USD |
NYSE |
Aug 25, 13:27
Takeda Pharmaceutical Price to Book Value : 1.243 for Aug. 25, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 1.240 |
| August 21, 2026 | 1.236 |
| August 20, 2026 | 1.232 |
| August 19, 2026 | 1.246 |
| August 18, 2026 | 1.227 |
| August 17, 2026 | 1.181 |
| August 14, 2026 | 1.198 |
| August 13, 2026 | 1.182 |
| August 12, 2026 | 1.183 |
| August 11, 2026 | 1.188 |
| August 10, 2026 | 1.193 |
| August 07, 2026 | 1.186 |
| August 06, 2026 | 1.157 |
| August 05, 2026 | 1.136 |
| August 04, 2026 | 1.126 |
| August 03, 2026 | 1.144 |
| July 31, 2026 | 1.162 |
| July 30, 2026 | 1.172 |
| July 29, 2026 | 1.206 |
| July 28, 2026 | 1.191 |
| July 27, 2026 | 1.185 |
| July 24, 2026 | 1.172 |
| July 23, 2026 | 1.143 |
| July 22, 2026 | 1.147 |
| July 21, 2026 | 1.171 |
| Date | Value |
|---|---|
| July 20, 2026 | 1.159 |
| July 17, 2026 | 1.166 |
| July 16, 2026 | 1.137 |
| July 15, 2026 | 1.118 |
| July 14, 2026 | 1.114 |
| July 13, 2026 | 1.121 |
| July 10, 2026 | 1.126 |
| July 09, 2026 | 1.129 |
| July 08, 2026 | 1.138 |
| July 07, 2026 | 1.153 |
| July 06, 2026 | 1.148 |
| July 02, 2026 | 1.140 |
| July 01, 2026 | 1.084 |
| June 30, 2026 | 1.090 |
| June 29, 2026 | 1.081 |
| June 26, 2026 | 1.076 |
| June 25, 2026 | 1.059 |
| June 24, 2026 | 1.064 |
| June 23, 2026 | 1.072 |
| June 22, 2026 | 1.047 |
| June 18, 2026 | 1.058 |
| June 17, 2026 | 1.043 |
| June 16, 2026 | 1.060 |
| June 15, 2026 | 1.067 |
| June 12, 2026 | 1.076 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Daiichi Sankyo Co., Ltd. | 3.128 |
| Ono Pharmaceutical Co., Ltd. | 1.345 |
| Astellas Pharma, Inc. | 2.256 |
| Sanofi | 1.544 |
| Eisai Co., Ltd. | 1.535 |
Price to Book Value Related Metrics
| PS Ratio | 1.947 |
| Price to Free Cash Flow | 21.68 |
| Price | 18.30 |
| Earnings Yield | -1.84% |
| Market Cap | 57.82B |
| Operating PE Ratio | 12.74 |